Cardiac arrest & resuscitation

Long-term heart function in refractory out-of-hospital cardiac arrest treated with prehospital extracorporeal cardiopulmonary resuscitation

ResuscitationPublished Retrospective observational study

Authors' conclusion

Most patients who were treated with prehospital ECPR for refractory OHCA due to ACS and survived with good neurological outcomes recovered a good heart function at one year, and half of them were working.

Study context

Population
Refractory out-of-hospital cardiac arrest (OHCA) caused by acute coronary syndrome (ACS) treated with prehospital extracorporeal cardiopulmonary resuscitation (ECPR), Paris, France, 2015–2023
Participants
114 participants
Outcome
NYHA functional class
Follow-up
One year
Methodological detailsmonocentric, Paris, France, January 1, 2015, to December 31, 2023
  • Monocentric
  • Paris, France, January 1, 2015, to December 31, 2023

Main finding

As reported in the abstract

New York Heart Association Functional Classification (NYHA-FC) among 1-year survivors with good neurological outcome (n=24)

Prehospital ECPR

1

median · IQR 1–1

Observational data: associations, not effects.

Further findings

Survival with good neurological outcome (CPC 1 or 2) · 1 year

Survived with good neurological outcome (CPC 1 or 2)
24/114 (21 %)

Left ventricular ejection fraction (LVEF) recovery (>50 %) among survivors with good neurological outcome · 1 year

Half recovered LVEF > 50 %

Ability to work among patients still alive · median follow-up 6.8 (3.6-8.0) years

Patients still alive
21
Median time to regain ability to work since OHCA onset
10 months (3-21)
Half actively working

Original publication

Long-term heart function in refractory out-of-hospital cardiac arrest treated with prehospital extracorporeal cardiopulmonary resuscitation. Resuscitation. Published 30 November 2024. doi:10.1016/j.resuscitation.2024.110449

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.